Christie Sun

Christie Sun

Auto-generated profile, based on publicly available information

Christie Sun

Division of Medical Toxicology, University of California San Diego, San Diego, California; Department of Emergency Medicine, University of California San Diego, San Diego, California

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Genetics
Verified
Journal Article
Closed access
PDF file
GCGerald B. Call
Gerald B. Call
JOJohn M. Olson
John M. Olson
JCJiong Chen
Jiong Chen
NVNikki Villarasa
Nikki Villarasa
KNKathy T. Ngo
Kathy T. Ngo
UBUtpal Banerjee
Utpal Banerjee
Using a large consortium of undergraduate students in an organized program at the University of California, Los Angeles (UCLA), we have undertaken a functional genomic screen in the Drosophila eye. In addition to the educational value of discovery-based learning, this article presents the first comprehensive genomewide analysis of essential genes involved in eye development. The data reveal the surprising result that the X chromosome has almost twice the frequency of essential genes involved in eye development as that found on the autosomes.

24 June 2016 in Journal of Medical Toxicology
Verified
Journal Article
Closed access
PDF file
MMMaryann Mazer-Amirshahi
Maryann Mazer-Amirshahi
CSChristie Sun
Christie Sun
PMPeter Mullins
Peter Mullins
JPJeanmarie Perrone
Jeanmarie Perrone
LNLewis Nelson
Lewis Nelson
JPJesse M. Pines
Jesse M. Pines

1 December 2016 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
RBRahul Bhat
Rahul Bhat
MMMaryann Mazer-Amirshahi
Maryann Mazer-Amirshahi
CSChristie Sun
Christie Sun
JVJanelle Vaughns
Janelle Vaughns
MDMaria Dynin
Maria Dynin
MGMunish Goyal
Munish Goyal

12 December 2017 in Clinical Toxicology
Verified
Journal Article
Closed access
CSChristie Sun
Christie Sun
KHKathryn A. Hollenbach
Kathryn A. Hollenbach
FCF. L. Cantrell
F. L. Cantrell
Background: In January 2012, carisoprodol was classified as a Schedule IV substance under the controlled substances act from a previously non-controlled, non-scheduled classification. Carisoprodol is marketed as a skeletal muscle relaxant and is commonly cited for its abuse potential. Objectives: We aimed to compare volume of calls involving carisoprodol abuse or misuse to a statewide poison control system before and after the scheduling change. Methods: Data were extracted from poison control calls coded as “misuse/abuse” involving carisoprodol from four years before (2008 to 2011) and four years after (2012 to 2015) the scheduling change. The volume of calls from pre- and post-scheduling change was compared after adjusting for yearly California census data. Results: The number of calls related to carisoprodol abuse or misuse was significantly decreased in the four years following the change compared to the four years before. Conclusion: Scheduling of carisoprodol was temporally related to decreased exposures as reported to California Poison Control Centers. Governmental regulation may impact a drug’s potential for abuse.

1 April 2018 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
CSChristie Sun
Christie Sun
JBJessica A. Brice
Jessica A. Brice
RCRichard F. Clark
Richard F. Clark

1 March 2018 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
CSChristie Sun
Christie Sun
BCBryan Corbett
Bryan Corbett